EFMH
JAZZ icon

E Fund Management (HK)’s Jazz Pharmaceuticals JAZZ Stock Holding History

E Fund Management (HK)’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.9K Buy
+79
New +$13.8K 0.01% 252

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

E Fund Management (HK)'s JAZZ Position: Q1 2026 in Review

E Fund Management (HK) opened a new position in Jazz Pharmaceuticals (JAZZ) in Q1 2026: 79 shares worth $14.9K. The stake represents 0.01% of the portfolio and ranks #252 among its holdings.

570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • E Fund Management (HK) held 79 shares of Jazz Pharmaceuticals worth $14.9K as of Q1 2026.
  • Jazz Pharmaceuticals was a new E Fund Management (HK) position in Q1 2026.
  • Jazz Pharmaceuticals made up 0.01% of E Fund Management (HK)'s portfolio in Q1 2026, its #252 holding.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on E Fund Management (HK)'s 13F filing for Q1 2026, filed 8 Apr 2026.